Feeds:
Posts
Comments

Archive for the ‘LPBI Group, e-Scientific Media, DFP, R&D-M3DP, R&D-Drug Discovery, US Patents: SOPs and Team Management’ Category


FIVE years of e-Scientific Publishing @pharmaceuticalintellicence.com,

Top Articles by Author and by e-Views >1,000,

4/27/2012 to 4/27/2017

 

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

FIVE years of e-Scientific Publishing  –  Top Articles by e-Views >1,000 for all days ending 2017-04-27 (Summarized)

@pharmaceuticalintellicence.com

 
Article Title
  Views All Time Author

Home page / Archives

445,321

e-Readers

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? 15,461 Larry H. Bernstein, MD, FCAP
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) 10,005  

Vivek Lal, MBBS, MD, FCIR, Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

Recent comprehensive review on the role of ultrasound in breast cancer management 7,513 Dror Nir, PhD
Paclitaxel vs Abraxane (albumin-bound paclitaxel) 6,721 Tilda Barliya, PhD
Our TEAM 5,722 Aviva Lev-Ari, PhD, RN
Mesothelin: An early detection biomarker for cancer (By Jack Andraka) 5,380 Tilda Barliya, PhD
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care 4,379 Aviva Lev-Ari, PhD, RN
Akt inhibition for cancer treatment, where do we stand today? 4,077 Ziv Raviv, PhD
Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses 3,847 Zohi Sternberg, PhD
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications 3,609 Aviva Lev-Ari, PhD, RN
Volume One: Perspectives on Nitric Oxide in Disease Mechanisms 3,456 Larry H. Bernstein, MD, FCAP, Stephen J Williams, PhD, Aviral Vatsa, PhD, et al.
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad 3,330 Demet Sag, PhD
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo 3,215 Stephen J Williams, PhD
Founder 3,131 Aviva Lev-Ari, PhD, RN
BioMed e-Series 3,005 Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN,

et al.

Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology 2,866 Tilda Barliya, PhD
The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets 2,854 Larry H. Bernstein, MD, FCAP, Justin D. Pearlman, MD, PhD and Aviva Lev-Ari, PhD, RN
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I 2,677 Larry H. Bernstein, MD, FCAP
VISION 2,651 Aviva Lev-Ari, PhD, RN
Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community 2,602 Justin D. Pearlman, MD, PhD, FACC, Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Funding, Deals & Partnerships 2,506 Aviva Lev-Ari, PhD, RN
FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules 2,461 Stephen J Williams, PhD
Bone regeneration and nanotechnology 2,446 Tilda Barliya, PhD
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging 2,400 Dror Nir, PhD
“The Molecular pathology of Breast Cancer Progression” 2,315 Tilda Barliya, PhD
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation 2,240 Larry H. Bernstein, MD, FCAP
Pacemakers, Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) 2,190 Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN
Targeting the Wnt Pathway [7.11] 2,162 Larry H. Bernstein, MD, FCAP
In focus: Circulating Tumor Cells 2,151 Ritu Saxena, PhD
Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical) 2,110 Justin D. Pearlman, MD, PhD, FACC, Larry H. Bernstein, MD, FCAP
AstraZeneca’s WEE1 protein inhibitor AZD1775 Shows Success Against Tumors with a SETD2 mutation 2,100 Stephen J Williams, PhD
Journal PharmaceuticalIntelligence.com 2,068 Aviva Lev-Ari, PhD, RN and  et al.
About 2,044 Aviva Lev-Ari, PhD, RN
Sexed Semen and Embryo Selection in Human Reproduction and Fertility Treatment 2,028 Sudipta Saha, PhD
Interaction of enzymes and hormones 1,994 Larry H. Bernstein, MD, FCAP
Problems of vegetarianism
1,908 Sudipta Saha, PhD
DNA Structure and Oligonucleotides 1,905 Larry H. Bernstein, MD, FCAP
Biosimilars: CMC Issues and Regulatory Requirements 1,813 Aviva Lev-Ari, PhD, RN
CD47: Target Therapy for Cancer 1,763 Tilda Barliya, PhD
Lipid Metabolism 1,761 Larry H. Bernstein, MD, FCAP
Peroxisome proliferator-activated receptor (PPAR-gamma) Receptors Activation: PPARγ transrepression for Angiogenesis in Cardiovascular Disease and PPARγ transactivation for Treatment of Diabetes 1,761 Aviva Lev-Ari, PhD, RN
Paclitaxel: Pharmacokinetic (PK), Pharmacodynamic (PD) and Pharmacogenpmics (PG) 1,725 Tilda Barliya, PhD
Non-small Cell Lung Cancer drugs – where does the Future lie? 1,720 Ritu Saxena, PhD
A Primer on DNA and DNA Replication 1,720 Larry H. Bernstein, MD, FCAP
Introduction to Tissue Engineering; Nanotechnology applications 1,711 Tilda Barliya, PhD
Nanotechnology: Detecting and Treating metastatic cancer in the lymph node 1,667 Tilda Barliya, PhD
Nitric Oxide Function in Coagulation – Part II 1,614 Larry H. Bernstein, MD, FCAP
The SCID Pig: How Pigs are becoming a Great Alternate Model for Cancer Research 1,603 Stephen J Williams, PhD
FDA Adds Cardiac Drugs to Watch List – TOPROL-XL® 1,578 Aviva Lev-Ari, PhD, RN
Outcomes in High Cardiovascular Risk Patients: Prasugrel (Effient) vs. Clopidogrel (Plavix); Aliskiren (Tekturna) added to ACE or added to ARB 1,542 Aviva Lev-Ari, PhD, RN
The role of biomarkers in the diagnosis of sepsis and patient management 1,500 Larry H. Bernstein, MD, FCAP
Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers 1,475 Aviva Lev-Ari, PhD, RN
Nanotechnology and MRI imaging 1,470 Tilda Barliya, PhD
Baby’s microbiome changing due to caesarean birth and formula feeding 1,457 Aviva Lev-Ari, PhD, RN
Cardiovascular Complications: Death from Reoperative Sternotomy after prior CABG, MVR, AVR, or Radiation; Complications of PCI; Sepsis from Cardiovascular Interventions 1,453 Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN
Dealing with the Use of the High Sensitivity Troponin (hs cTn) Assays 1,424 Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Clinical Trials Results for Endothelin System: Pathophysiological role in Chronic Heart Failure, Acute Coronary Syndromes and MI – Marker of Disease Severity or Genetic Determination? 1,417 Aviva Lev-Ari, PhD, RN
Neonatal Pathophysiology 1,412 Larry H. Bernstein, MD, FCAP
Competition in the Ecosystem of Medical Devices in Cardiac and Vascular Repair: Heart Valves, Stents, Catheterization Tools and Kits for Open Heart and Minimally Invasive Surgery (MIS) 1,408 Aviva Lev-Ari, PhD, RN
Justin D. Pearlman, AB, MD, ME, PhD, MA, FACC, Expert, Author, Writer, Editor & Content Consultant for e-SERIES A: Cardiovascular Diseases 1,396 Justin D. Pearlman, MD, PhD, FACC
IDO for Commitment of a Life Time: The Origins and Mechanisms of IDO, indolamine 2, 3-dioxygenase 1,384 Demet Sag, PhD
UPDATED: PLATO Trial on ACS: BRILINTA (ticagrelor) better than Plavix® (clopidogrel bisulfate): Lowering chances of having another heart attack 1,360 Aviva Lev-Ari, PhD, RN
Monoclonal Antibody Therapy and Market 1,352 Demet Sag, PhD
Mitochondrial Damage and Repair under Oxidative Stress 1,315 Larry H. Bernstein, MD, FCAP
Closing the Mammography gap 1,292 Dror Nir, PhD
Cardio-oncology and Onco-Cardiology Programs: Treatments for Cancer Patients with a History of Cardiovascular Disease 1,288 Aviva Lev-Ari, PhD, RN
Update on FDA Policy Regarding 3D Bioprinted Material 1,286 Aviva Lev-Ari, PhD, RN
Mitral Valve Repair: Who is a Patient Candidate for a Non-Ablative Fully Non-Invasive Procedure? 1,276 Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN
Aviva Lev-Ari, PhD, RN, Director and Founder 1,250 Aviva Lev-Ari, PhD, RN
Diagnostic Evaluation of SIRS by Immature Granulocytes 1,249 Larry H. Bernstein, MD, FCAP
Nitric Oxide, Platelets, Endothelium and Hemostasis (Coagulation Part II) 1,238 Larry H. Bernstein, MD, FCAP
Signaling and Signaling Pathways 1,235 Larry H. Bernstein, MD, FCAP
Crucial role of Nitric Oxide in Cancer 1,215 Ritu Saxena, PhD
Triple Antihypertensive Combination Therapy Significantly Lowers Blood Pressure in Hard-to-Treat Patients with Hypertension and Diabetes 1,211 Aviva Lev-Ari, PhD, RN
Mitochondrial fission and fusion: potential therapeutic targets? 1,203 Ritu Saxena, PhD
Diet and Diabetes 1,186 Larry H. Bernstein, MD, FCAP
Mitochondrial Dynamics and Cardiovascular Diseases 1,171 Ritu Saxena, PhD
Nanotechnology and Heart Disease 1,159 Tilda Barliya, PhD
Nitric Oxide and Immune Responses: Part 2 1,153 Aviral Vatsa, PhD
Transcatheter Aortic Valve Implantation (TAVI): FDA approves expanded indication for two transcatheter heart valves for patients at intermediate risk for death or complications associated with open-heart surgery 1,153 Aviva Lev-Ari, PhD, RN
The Final Considerations of the Role of Platelets and Platelet Endothelial Reactions in Atherosclerosis and Novel Treatments 1,149 Larry H. Bernstein, MD, FCAP
‘Gamifying’ Drug R&D: Boehringer Ingelheim, Sanofi, Eli Lilly 1,128 Aviva Lev-Ari, PhD, RN
Scientific and Medical Affairs Chronological CV 1,127 Aviva Lev-Ari, PhD, RN
Assessing Cardiovascular Disease with Biomarkers 1,122 Larry H. Bernstein, MD, FCAP
Issues in Personalized Medicine in Cancer: Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing 1,116 Stephen J Williams, PhD
Liver Toxicity halts Clinical Trial of IAP Antagonist for Advanced Solid Tumors 1,112 Stephen J Williams, PhD
Nitric Oxide has a Ubiquitous Role in the Regulation of Glycolysis – with a Concomitant Influence on Mitochondrial Function 1,111 Larry H. Bernstein, MD, FCAP
Nanotechnology and HIV/AIDS treatment 1,109 Tilda Barliya, PhD
Interview with the co-discoverer of the structure of DNA: Watson on The Double Helix and his changing view of Rosalind Franklin 1,107 Aviva Lev-Ari, PhD, RN
Ultrasound-based Screening for Ovarian Cancer 1,105 Dror Nir, PhD
Stenting for Proximal LAD Lesions 1,082 Aviva Lev-Ari, PhD, RN
Treatment of Refractory Hypertension via Percutaneous Renal Denervation 1,082 Aviva Lev-Ari, PhD, RN
Nitric Oxide and it’s impact on Cardiothoracic Surgery 1,079 Tilda Barliya, PhD
Wnt/β-catenin Signaling [7.10] 1,078 Larry H. Bernstein, MD, FCAP
Disruption of Calcium Homeostasis: Cardiomyocytes and Vascular Smooth Muscle Cells: The Cardiac and Cardiovascular Calcium Signaling Mechanism 1,068 Larry H. Bernstein, MD, FCAP,             Justin D. Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN
Unique Selling Proposition (USP) — Building Pharmaceuticals Brands 1,063 Aviva Lev-Ari, PhD, RN
Patiromer – New drug for Hyperkalemia 1,054 Aviva Lev-Ari, PhD, RN
Isoenzymes in cell metabolic pathways 1,048 Larry H. Bernstein, MD, FCAP
Sex Hormones 1,039 Larry H. Bernstein, MD, FCAP
LPBI Group 1,027 Aviva Lev-Ari, PhD, RN
Survivals Comparison of Coronary Artery Bypass Graft (CABG) and Percutaneous Coronary Intervention (PCI) / Coronary Angioplasty 1,027 Larry H. Bernstein, MD, FCAP and Aviva Lev-Ari, PhD, RN
Targeted delivery of therapeutics to bone and connective tissues: current status and challenges- Part I 1,020 Aviral Vatsa, PhD
Overview of New Strategy for Treatment of T2DM: SGLT2 Inhibiting Oral Antidiabetic Agents 1,015 Aviral Vatsa, PhD
Ovarian Cancer and fluorescence-guided surgery: A report 1,012 Tilda Barliya, PhD
Bystolic’s generic Nebivolol – Positive Effect on circulating Endothelial Progenitor Cells Endogenous Augmentation 1,012 Aviva Lev-Ari, PhD, RN
Low Bioavailability of Nitric Oxide due to Misbalance in Cell Free Hemoglobin in Sickle Cell Disease – A Computational Model 1,011 Anamika Sarkar, PhD
New England Compounding Center: A Family Business 1,008 Alan F. Kaul, PharmD
Integrins, Cadherins, Signaling and the Cytoskeleton 1,003 Larry H. Bernstein, MD, FCAP
Advertisements

Read Full Post »


Top Authors, by 5 years of e-Views, 4/25/2017, on pharmaceuticalintelligence.com

Reporter: Aviva Lev-Ari, PhD, RN

 

Top Authors for all days ending 2017-04-25 (Summarized)

All Time

4/30/2012 – 4/25/2017

Author

Views

Aviva Lev-Ari, PhD, RN 315,262
 

Larry H Bernnstein, MD, FCAP
220,787
Tilda Barliya, PhD 47,008
 

Stephen J Williams, PhD
39,704
Dror Nir, PhD
24,484
Sudipta Saha, PhD
22,253
Ritu Saxena, PhD
15,302
Demet Sag, Ph.D., CRA, GCP
12,982
Aviral Vatsa, PhD
8,082
Ziv Raviv, PhD
7,525
Zohi Sternberg, PhD
3,839
Anamika Sarkar, PhD, MBA
3,269
Gail S Thornton, MA, PhD(c)
2,885
Danut Dragoi, PhD
2,607
Prabodh Kandala, PhD
2,115
Alan F. Kaul, PharmD., MS, MBA, FCCP
2,057
Aashir Awan, PhD
1,841
Meg Baker, PhD
1,439
Justin D Pearlman, MD, PhD
1,429
Irina Robu, PhD
949
S. Chakrabarti, Ph.D. 622

 

 

Read Full Post »


We celebrate 5,070 Scientific Articles – pharmaceuticalintelligence.com –

Top Posts with Greater than 2,000 Views

 

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

Website Statistics on April 12, 2017, 3:09 PM – All time

 

1,193,720 views

7,267 comments

 

Content

5,070 Scientific Articles

572 Categories

9,557 Tags

 

Referrers for all days ending 2017-04-12 (Summarized)

All Time

Referrer Views
Search Engines 609,953
linkedin.com 24,279
Facebook 6,905
lnkd.in 6,262
scholar.google.com 3,565
Twitter 3,093
investorshub.advfn.com 1,072
WordPress Dashboard 902
android-app 862
scoop.it 802
mail.yahoo.com 765
scholar.google.co.in 473
scholar.google.co.uk 438
 

 

Clicks for all days ending 2017-04-12 (Summarized)

URL Clicks
WordPress.com Media 30,683
commons.wikipedia.org 6,013
http://www.ncbi.nlm.nih.gov 3,652
en.wikipedia.org 3,151
http://www.nature.com 2,565
dx.doi.org 1,309
http://www.scoop.it 970
pharmaceuticalintelligence.wordpress.com 736
http://www.sciencedirect.com 654
gravatar.com 627
http://www.fda.gov 519
apps.societyforscience.org/intelisef2012/project.cfm?PID=ME028&CFID=28485&CFTOKEN=10931553 514
http://www.cancer.gov 419
http://www.medscape.com 384

 

Top Posts with Greater than 2,000 Views for all days ending 2017-04-12 (Summarized)

 

Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

15,394
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) 9,916
Recent comprehensive review on the role of ultrasound in breast cancer management 7,426
Paclitaxel vs Abraxane (albumin-bound paclitaxel) 6,594
Our TEAM 5,708
Mesothelin: An early detection biomarker for cancer (By Jack Andraka) 5,349
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care 4,272
Akt inhibition for cancer treatment, where do we stand today? 4,047
Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses 3,829
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications 3,536
Volume One: Perspectives on Nitric Oxide in Disease Mechanisms 3,452
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad 3,318
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo 3,207
Founder 3,128
BioMed e-Series 3,000
Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology 2,852
The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets 2,845
The mechanism of action of the drug ‘Acthar’ for Systemic Lupus Erythematosus (SLE) 2,830
VISION 2,638
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I 2,636
Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community 2,595
Funding, Deals & Partnerships 2,500
FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules 2,439
Bone regeneration and nanotechnology 2,425
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging 2,382
“The Molecular pathology of Breast Cancer Progression” 2,307
Pacemakers, Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) 2,175
In focus: Circulating Tumor Cells 2,147
Targeting the Wnt Pathway [7.11] 2,143
Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical) 2,103
Journal PharmaceuticalIntelligence.com 2,062
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation 2,046
About 2,043
Sexed Semen and Embryo Selection in Human Reproduction and Fertility Treatment 2,008
AstraZeneca’s WEE1 protein inhibitor AZD1775 Shows Success Against Tumors with a SETD2 mutation 2,008

 

Read Full Post »


Year End 2016 Statement on Yearly Progress by LPBI Group

Curator: Aviva Lev-Ari, PhD, RN

LPBI Group has Three Enterprise Types and Five Subsidiaries

pharma_bi-background0238 copy

 Image Source: Google Images

We are in Knowledge-based Informational Services

 

  • Subsidiary 1: Digital Media and e-Scientific Publishing

Line-of-Business #1:

Open Access OnLine Scientific Journal  

1,121,301 e-Readers, Site Statistics on 12/26/2016 

Editor-in-Chief: Aviva Lev-Ari, PhD, RN

5,005 Scientific Articles, Site Statistics on 12/26/2016 

Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN

Curator: Aviva Lev-Ari, PhD, RN

 

  • 7,267 Comments by Scientists, Site Statistics on 12/26/2016 
  • 2,183 Subscribers, Site Statistics on 12/26/2016

Line-of-Business #2:

BioMed e-Series, Five Series in Medicine, 8 e-Books on Amazon.com, 7 e-Books in 2017

New e-Book TITLES forthcoming on Amazon.com in 2016 from LPBI Group’s BioMed e-Series –Forthcoming COVER PAGES

Editor-in-Chief, Aviva Lev-Ari, PhD, RN

 

Line-of-Business #3:

Real Time Press Coverage of BioTech Global Premier Conferences, Portfolio of ~30 events

Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016

Curator: Aviva Lev-Ari, PhD, RN

Line-of-Business #4: No Progress in 2016

Audio-Podcast Series in Medicine, 5 tracks

&

  • Subsidiary 4: Intellectual Property Asset Management

Line-of-Business #5: New Patents issued to Bill Zurn

Representation of US Patent Holders for Commercialization, Licensing and Partnerships

We are in Research Biotech Businesses

 

  • Subsidiary 3: R&D in 3D BioPrinting

Line-of-Business #6:

Tissue Engineering, Gene Therapy: Stem Cells & Gene Editing, Medical Devices: Product Concepts

Curator: Aviva Lev-Ari, PhD, RN

Technologies for Patient-centered Medicine: From R&D in Biologics to New Medical Devices

&

  • Subsidiary 5: Pharmaceutical R&D: Drug Discovery and Drug-Devices Development

 

Line-of-Business #7:

Team developing new mechanism of action for Therapeutics and Diagnostics for Early Detection of Pancreatic Cancer

 

Line-of-Business #8:

Team developing solutions with Nanoparticles and with Exosomes 

We are in Business Financial Transactions (No Securities Traded)

 

  • Subsidiary 2: Funding Early Stage Businesses, IP Licensing and Business Partnerships:

Line-of-Business #9:

Early Stage Venture Funding

MEDICAL DEVICES

Pharmaceutical Informational PLATFORMS

INVENTIONS IN BIOLOGICS

Representation of 13 ventures for the purpose of prospecting for funding. Seeking business partner to developing FUNDING of the following Ventures, if interested to further explore jointly, please e-mail me:

avivalev-ari@alum.berkeley.edu

 

LPBI Group’s Portfolio of Clients include the following:

 

  1. Woodland Pharmaceutical

https://gust.com/companies/woodland_pharmaceuticals

 

  1. BioTerm Pharmaceuticals

http://www.bio-term.com/

 

  1. Akshaya Bio Inc. – Portfolio of 28 Patents in vaccine – viral infection

http://www.akshayabio.com/

 

  1. com

http://www.valvecure.com/Home.html

 

  1. Alpha Sensors, Inc.

http://alphaszenszor.com/

 

  1. AlphaIP, Inc.

http://www.alphaip.net/

 

  1. SBH Sciences, Inc

http://www.sbhsciences.com/

 

  1. Telerescue

http://www.telerescue.co.il/

 

  1. New Medicine, Inc.

http://www.newmedinc.com/

 

  1. LPBI Group – Aviva Lev-Ari, PhD, RN – Founder

https://pharmaceuticalintelligence.com/gama-delta-epsilon-gde-is-a-global-holding-company-absorbing-lpbi/

 

10a. DrugDiscovery @LPBI Group – Aviva Lev-Ari, PhD, RN – Co–Founder and Raphael Nir, PhD – Co–Founder

https://pharmaceuticalintelligence.com/drugdiscovery-lpbi-group/

 

  1. Portfolio of Patents of S.Y. in Anti-Inflammatory, A Macro Molecule of a Multifunctional NSAID – Portfolio of 13 US Patents

Multi-Functional Anti-Inflammatory Drugs (MFAIDs): Small Molecule Invention of Dr. Saul Yedgar, HUJI and Yissum

 

  1. Portfolio of Patents under management of Y. M.

 

  1. Vyriad – Oncolytic Virotherapy for the Treatment of Cancer
    Vyriad – http://www.vyriad.com/

Read Full Post »


We Celebrate 5,000 Scientific Articles @pharmaceuticalintelligence.com – 2016 was a GREAT Year !!!!!

Curator and Open Access Journal Editor-in-Chief: Aviva Lev-Ari, PhD, RN

 

April 30, 2012: Launch Date for 1st Article

December 19, 2016: Date we Celebrate 5,000 Scientific Articles and 1,118,520 e-Readers 

For 2016, Our Top Articles by e-Readers Views and Authors are:

Top Posts for 365 days ending 2016-12-19 (Summarized)

Year |

2015-12-20 to Today

Article Title
e-Views

>500

Home page / Archives 119,586
 

Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran)

Curators: Vivek Lal, MBBS, MD, FCIR, Justin D Pearlman, MD, PhD, FACC and Article Curator: Aviva Lev-Ari, PhD, RN

2,815
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View?

Author: Larry H. Bernstein, MD, FCAP  

2,501
Paclitaxel vs Abraxane (albumin-bound paclitaxel)

Author: Tilda Barliya, PhD

1,949
Recent comprehensive review on the role of ultrasound in breast cancer management

Writer, Reporter and Curator: Dror Nir, PhD

1,785
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care

Curator: Aviva Lev-Ari, PhD, RN

1,523
AstraZeneca’s WEE1 protein inhibitor AZD1775 Shows Success Against Tumors with a SETD2 mutation

Curator: Stephen J. Williams, PhD

1,380
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications

Curator: Aviva Lev-Ari, PhD, RN

1,256
Akt inhibition for cancer treatment, where do we stand today?

Author: Ziv Raviv, PhD

1,130
Targeting the Wnt Pathway [7.11]

Writer and Curator: Larry H Bernstein, MD, FCAP 

923
Monoclonal Antibody Therapy and Market

Author and Curator: Demet Sag, PhD, CRA, GCP 

888
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

Author/ Curator:  Tilda Barliya PhD

819
Lipid Metabolism

Reporter and Curator: Larry H. Bernstein, MD, FCAP 

808
Update on FDA Policy Regarding 3D Bioprinted Material

Curator: Stephen J. Williams, PhD

716
The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets

Author and Curator: Larry H Bernstein, MD, FCAP

Author, and Content Consultant to e-SERIES A: Cardiovascular Diseases: Justin Pearlman, MD, PhD, FACC

and

Curator: Aviva Lev-Ari, PhD, RN

676
Sexed Semen and Embryo Selection in Human Reproduction and Fertility Treatment

Reporter and Curator: Dr. Sudipta Saha, PhD

667
In focus: Circulating Tumor Cells

Author/Curator: Ritu Saxena, PhD

642
A Primer on DNA and DNA Replication

Reporter and Curator: Larry H. Bernstein, MD, FCAP 

622
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging

Reporter: Dror Nir, PhD

614
Our TEAM 599
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad

Curator: Demet Sag, PhD, CRA, GCP

596
Pacemakers, Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT)

Curators: Justin D Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN

583
LPBI Group 575
U.S. FDA advisers recommend approval of Cinqair (Reslizumab,Teva) asthma drug for adults

Reporter: Aviva Lev-Ari, PhD, RN

568
FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules

Author-Writer: Stephen J. Williams, PhD

560
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I

Curator, Editor and Writer: Larry H. Bernstein, MD, FCAP 

559
Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community

Authors and Curators: Larry H Bernstein, MD, FCAP and Justin D Pearlman, MD, PhD, FACC

and

Article Curator and Reporter: Aviva Lev-Ari, PhD, RN

549
7th Annual – CHI’s Inflammation Inhibitors Small Molecule and Macrocyclic Approaches, April 19-20, 2016 Hilton San Diego Resort and Spa

Reporter: Aviva Lev-Ari, PhD, RN

536
Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses

Curator: Zohi Sternberg, PhD

525
LIK 066, Novartis, for the treatment of type 2 diabetes

Curator: Larry H. Bernstein, MD, FCAP

524
Who will be the the First to IPO: Novartis bought in to Intellia (UC, Berkeley) as well as Caribou (UC, Berkeley) vs Editas (MIT)??

Reporter: Aviva Lev-Ari, PhD, RN

516
Interaction of enzymes and hormones

Reporter and Curator: Dr. Sudipta Saha, PhD

507
Autophagy

Writer and Curator: Larry H Bernstein, MD, FCAP

500

 

These articles and others are in EIGHT e-Books on Amazon.com

Forthcoming SEVEN e-Books in 2016

https://www.linkedin.com/pulse/forthcoming-cover-pages-new-e-books-medicine-from-lev-ari-phd-rn?trk=prof-post

WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

BioMedical e-Books e-Series:

Cardiovascular, Genomics, Cancer, BioMed, Patient Centered Medicine

https://pharmaceuticalintelligence.com/biomed-e-books/

2013 e-Book on Amazon.com

  • Perspectives on Nitric Oxide in Disease Mechanisms, on Amazon since 6/2/12013

http://www.amazon.com/dp/B00DINFFYC

2015 e-Book on Amazon.com

 

http://www.amazon.com/dp/B012BB0ZF0

  • Cancer Biology & Genomics for Disease Diagnosis, on Amazon since 8/11/2015

http://www.amazon.com/dp/B013RVYR2K

  • Genomics Orientations for Personalized Medicine, on Amazon since 11/23/2015

http://www.amazon.com/dp/B018DHBUO6

  • Milestones in Physiology: Discoveries in Medicine, Genomics and Therapeutics, on Amazon.com since 12/27/2015

http://www.amazon.com/dp/B019VH97LU

  • Cardiovascular, Volume Two: Cardiovascular Original Research: Cases in Methodology Design for Content Co-Curation, on Amazon since 11/30/2015

http://www.amazon.com/dp/B018Q5MCN8

  • Cardiovascular Diseases, Volume Three: Etiologies of Cardiovascular Diseases: Epigenetics, Genetics and Genomics, on Amazon since 11/29/2015

http://www.amazon.com/dp/B018PNHJ84

  • Cardiovascular Diseases, Volume Four: Regenerative and Translational Medicine: The Therapeutics Promise for Cardiovascular Diseases, on Amazon since 12/26/2015

http://www.amazon.com/dp/B019UM909A

flyersseiesedot16future

flyer-for-series-a-dot16

flyersabcd2-dot16future

flyer2forApril2016BioWorld

flyer1forApril2016BioWorld

Read Full Post »


Super RECORD of REAL TIME Coverage of Biotech and Medicine Conferences by LPBI Group in 2016

Curator: Aviva Lev-Ari, PhD, RN

 

2013 to Present List of BioTech Conferences covered in Real Time

https://pharmaceuticalintelligence.com/press-coverage/

2016 List of BioTech Conferences covered in Real Time

 

  • The 12th Annual Personalized Medicine Conference, NOVEMBER 15 – 17, 2016, Joseph B. Martin Conference Center, HARVARD MEDICAL SCHOOL, Boston

https://pharmaceuticalintelligence.com/2016/05/13/the-12th-annual-personalized-medicine-conference-november-15-17-2016-joseph-b-martin-conference-center-harvard-medical-school-boston/

 

  • The 16th annual EmTech MIT – A Place of Inspiration, October 18-20, 2016, Cambridge, MA

The 16th annual EmTech MIT – A Place of Inspiration, October 18-20, 2016, Cambridge, MA

Agenda @Biotech Week Boston: WHERE THE HEART, TECHNOLOGY AND BUSINESS OF SCIENCE CONVERGE, Conference: October 4 – 7, 2016 | Exhibition: October 5-7, 2016 Boston Convention and Exhibition Center

 

  • CHI’s 14th Annual Discovery on Target: Preliminary Agenda Available and Exclusive Discount to attend Boston’s Discovery on Target (September 19-22, 2016)

https://pharmaceuticalintelligence.com/2016/05/11/chis-14th-annual-discovery-on-target-preliminary-agenda-available-and-exclusive-discount-to-attend-bostons-discovery-on-target-september-2016/

 

  • Understanding CRISPR: Mechanisms and Applications: CHI, September 19-22, 2016, Westin Boston Waterfront, Boston

Preliminary Agenda Available and Exclusive Discount to attend Understanding CRISPR: Mechanisms to Applications Symposium in Boston (September 19, 2016)

https://pharmaceuticalintelligence.com/2016/04/06/understanding-crispr-mechanisms-and-applications-chi-september-19-22-2016-westin-boston-waterfront-boston/

 

Announcement from LPBI Group: key code LPBI16 for Exclusive Discount to attend Boston’s Discovery on Target (September 19-22, 2016, CRISPR: Mechanisms to Applications on 9/19/2016)

https://pharmaceuticalintelligence.com/2016/05/13/announcement-from-lpbi-group-key-code-lpbi16-for-exclusive-discount-to-attend-bostons-discovery-on-target-september-2016/

 

  • Oncolytic Virus Immunotherapy Unlocking Oncolytic Virotherapies: From Science to Commercialization CHI’S 4TH ANNUAL IMMUNO-ONCOLOGY SUMMIT – AUGUST 29-30, 2016 | Marriott Long Wharf Hotel – Boston, MA

https://pharmaceuticalintelligence.com/2016/07/15/agenda-for-oncolytic-virus-immunotherapy-unlocking-oncolytic-virotherapies-from-science-to-commercialization-chis-4th-annual-immuno-oncology-summit-august-29-30-2016-marriott-lo/

 

  • CHI’S 4THANNUAL IMMUNO-ONCOLOGY SUMMIT – Personalized Immunotherapy | The Immuno-Oncology Summit Personalized Oncology in the Genomic Era: Expanding the Druggable Space, August 30-31, 2016 | Marriott Long Wharf Hotel – Boston, MA

https://pharmaceuticalintelligence.com/2016/07/14/personalized-immunotherapy-the-immuno-oncology-summit-august-30-31-2016-boston-ma/

 

  • 10th US-India BioPharma & Healthcare Summit, Thursday, June 2, 2016, Marriott Cambridge, MA

https://pharmaceuticalintelligence.com/2016/05/24/10th-us-india-biopharma-healthcare-summit-thursday-june-2-2016-marriott-cambridge-ma/

 

  • 2016 World Medical Innovation Forum: CANCER, April 25-27, 2016, Partners HealthCare, Boston, at the Westin Hotel, Boston

https://pharmaceuticalintelligence.com/2015/12/02/2016-world-medical-innovation-forum-cancer-april-25-27-2016-partners-healthcare-boston-at-the-westin-hotel-boston/

 

  • 2016 MassBio Annual Meeting  03/31/2016 8:00 AM – 04/01/2016 3:00 PM Royal Sonesta, Cambridge MA

https://pharmaceuticalintelligence.com/2016/03/02/2016-massbio-annual-meeting-03312016-800-am-04012016-300-pm-royal-sonesta-cambridge-ma/

 

Press Coverage is a Service that we offer to Biotech and Medicine, Scientific and Business Conference Organizers.

 

Channels for e-Marketing of Biotech Conferences

 

 

  • Our Journal has +1,115,681 eReaders on 12/14/2016, for All Time

http://pharmaceuticalintelligence.com

 

  • Aviva’s – +6000 BIOTECH followers on LinkedIn

http://www.linkedin.com/in/avivalevari

 

  • LPBI Group’s FaceBook Page

http://www.facebook.com/LeadersInPharmaceuticalBusinessIntelligence

 

  • LPBI Group’s Twitter Account

http://twitter.com/pharma_BI

 

  • Aviva Manages three Groups on LinkedIn

 

a.       Cardiovascular Biotech & Pharma UK & US Networking Group

906 members

https://www.linkedin.com/groups/4357927

 

b.       Leaders in Pharmaceutical Business Intelligence

336 members

https://www.linkedin.com/groups/4346921

 

c.         Innovation in Israel

172 members

https://www.linkedin.com/groups/2987122

 

  • LPBI Group’s Company’s Page on LinedIn

https://www.linkedin.com/company/9325543?trk=tyah&trkInfo=clickedVertical%3Acompany%2CclickedEntityId%3A9325543%2Cidx%3A1-1-1%2CtarId%3A1439226813927%2Ctas%3ALeaders%20in%20Pharmaceutica

Deliverables for 2016 Biotech Conference Coverage

https://pharmaceuticalintelligence.com/press-coverage/

 

Read Full Post »


Top Authors for All Days ending 2016-12-01: GROWTH Trends @Leaders in Pharmaceutical Business Intelligence (LPBI) Group

 

Curator: Aviva Lev-Ari, PhD, RN

 

Date |Views to Date |# of articles |NIH Clicks |Nature Clicks

12/1/2016 1,107,643  4,972 3,398  2,279

Be proud to be part of this team !!!

Forthcoming SEVEN e-Books in 2016 AND Eight e-Books on Amazon.com

https://pharmaceuticalintelligence.com/2016/04/24/new-e-book-titles-forthcoming-on-amazon-com-in-2016-from-lpbi-groups-biomed-e-series-forthcoming-cover-pages/

WE ARE ON AMAZON.COM

http://www.amazon.com/dp/B00DINFFYC

http://www.amazon.com/dp/B018Q5MCN8

http://www.amazon.com/dp/B018PNHJ84

http://www.amazon.com/dp/B018DHBUO6

http://www.amazon.com/dp/B013RVYR2K

http://www.amazon.com/dp/B012BB0ZF0

http://www.amazon.com/dp/B019UM909A

http://www.amazon.com/dp/B019VH97LU

 

GROWTH TRENDS: e-Readers, # of articles, NIH Clicks, Nature Clicks

2013, 2014, 2015, 2016

Scientific Journal Site Statistics

Date |Views to Date |# of articles |NIH Clicks |Nature Clicks

07/29/2013   217,356 1,138 1,389 705

12/01/2013   287,645 1,428 1,676 828

02/09/2014   325,039 1,665 1,793 892

03/05/2014   338,958 1,717 1,830 965

03/21/2014   347,667 1,750 1,838 974

03/31/2014  352,683 1,768 1,869 991

05/12/2014  373.696  1,878  1,944  1,035

06/18/2014  393,111  1,992  1,982  1,087

7/27/2014  418,570  2,098  2.050  1,124

9/2/2014  444,222  2,226  2,104  1,170

10/9/2014 471,117  2,337  2,147  1,216

11/4/2014  492,736  2,471  2,194 1,234

2/15/2015  572,027 2,727  2,358  1,345

3/10/2015 591,520 2,808 2,373 1,369

6/7/2015   661,215 3,007 2,562 1,535

7/27/2015 694,298 3,085 2,583 1,572

8/18/2015 709,609  3,173 2,613 1,573

02/18/2016  886,454  4,162   2,911  1,813 

Date |Views to Date |# of articles |NIH Clicks |Nature Clicks

12/1/2016 1,107,643  4,972 3,398  2,279

 

Be proud to be part of this team !!!

 

Top Authors for all days ending 2016-12-01 (Summarized)

Author Views
Aviva Lev-Ari, PhD, RN 295,929
larryhbern 203,736
tildabarliya 43,869
sjwilliamspa 35,934
Dror Nir 23,073
Dr. Sudipta Saha 19,509
ritusaxena 14,934
 
Demet Sag, Ph.D., CRA, GCP 12,025
aviralvatsa 7,942
zraviv06 7,176
zs22 3,738
anamikasarkar 3,182
danutdaagmailcom 2,283
pkandala 2,097
Gail S Thornton 2,035
Alan F. Kaul, PharmD., MS, MBA, FCCP 1,975
Aashir Awan, Phd 1,775
megbaker58 1,408
jdpmd 1,345
Irina Robu 879
Ed Kislauskis 546
howarddonohue 521
evelinacohn 344
David Orchard-Webb, PhD 341
apreconasia 332
stuartlpbi 252
jukkakarjalainen 226
gerag2015 90
kellyperlman 59
Rosalind Codrington, PhD 29
Debashree 22

 

 Top Posts for all days ending 2016-12-03 (Summarized)

 

 All Time  
 
Title
  Views
Home page / Archives 402,487
Is the Warburg Effect the Cause or the Effect of Cancer: A 21st Century View? – Dr. Larry Bernstein 14,861
Do Novel Anticoagulants Affect the PT/INR? The Cases of XARELTO (rivaroxaban) and PRADAXA (dabigatran) Aviva Lev-Ari, et al 9,080
Recent comprehensive review on the role of ultrasound in breast cancer management Dr. Dror Nir 6,720
Paclitaxel vs Abraxane (albumin-bound paclitaxel) Tilda Barliya, PhD 5,695
Our TEAM  Aviva Lev-Ari, PhD, RN 5,539
Mesothelin: An early detection biomarker for cancer (By Jack Andraka)

Tilda Barliya, PhD

5,051
Akt inhibition for cancer treatment, where do we stand today?

Ziv Raviv, PhD

3,843
Newer Treatments for Depression: Monoamine, Neurotrophic Factor & Pharmacokinetic Hypotheses – Zohi Sternberg, PhD 3,740
Clinical Indications for Use of Inhaled Nitric Oxide (iNO) in the Adult Patient Market: Clinical Outcomes after Use, Therapy Demand and Cost of Care – Dr. Justin Pearlman and Aviva Lev-Ari, PhD, RN 3,418
Volume One: Perspectives on Nitric Oxide in Disease Mechanisms

Editors: Dr. Larry Bernstein, Aviral Vatsa, PhD and Stephen J Williams, PhD

3,389
Confined Indolamine 2, 3 dioxygenase (IDO) Controls the Hemeostasis of Immune Responses for Good and Bad – Demet Sag, PhD 3,181
AMPK Is a Negative Regulator of the Warburg Effect and Suppresses Tumor Growth In Vivo – Stephen J Williams, PhD 3,149
Apixaban (Eliquis): Mechanism of Action, Drug Comparison and Additional Indications – Aviva Lev-Ari, PhD, RN 3,082
Founder  Aviva Lev-Ari, PhD, RN 3,075
BioMed e-Series – Aviva Lev-Ari, PhD, RN 2,944
The mechanism of action of the drug ‘Acthar’ for Systemic Lupus Erythematosus (SLE) Aviva Lev-Ari, PhD, RN et al 2,728
Introduction to Transdermal Drug Delivery (TDD) system and nanotechnology – Tilda Barliya, PhD 2,728
The Centrality of Ca(2+) Signaling and Cytoskeleton Involving Calmodulin Kinases and Ryanodine Receptors in Cardiac Failure, Arterial Smooth Muscle, Post-ischemic Arrhythmia, Similarities and Differences, and Pharmaceutical Targets –  Dr. Larry Bernstein, Dr. Justin Pearlman and Aviva Lev-Ari, PhD, RN 2,715
VISION  Aviva Lev-Ari, PhD, RN 2,527
Alternative Designs for the Human Artificial Heart: Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant Patient in the Community – Dr. Larry Bernstein, Dr. Justin Pearlman and Aviva Lev-Ari, PhD, RN 2,487
Funding, Deals & Partnerships – Aviva Lev-Ari, PhD, RN 2,436
Biochemistry of the Coagulation Cascade and Platelet Aggregation – Part I

Dr. Larry Bernstein

2,318
FDA Guidelines For Developmental and Reproductive Toxicology (DART) Studies for Small Molecules –  Stephen J Williams, PhD 2,260
Bone regeneration and nanotechnology –  – Tilda Barliya, PhD 2,252
“The Molecular pathology of Breast Cancer Progression” –  – Tilda Barliya, PhD 2,233
Causes and imaging features of false positives and false negatives on 18F-PET/CT in oncologic imaging – Dror Nir, PhD 2,150
About  Aviva Lev-Ari, PhD, RN 2,036
In focus: Circulating Tumor Cells – Ritu Saxena, PhD 2,034
Mitochondria: Origin from oxygen free environment, role in aerobic glycolysis, metabolic adaptation – Dr. Larry Bernstein 2,016
Treatment Options for Left Ventricular Failure – Temporary Circulatory Support: Intra-aortic balloon pump (IABP) – Impella Recover LD/LP 5.0 and 2.5, Pump Catheters (Non-surgical) vs Bridge Therapy: Percutaneous Left Ventricular Assist Devices (pLVADs) and LVADs (Surgical)

Larry H Bernstein, MD, FCAP and Justin D Pearlman, MD, PhD, FACC

1,983
Journal PharmaceuticalIntelligence.com – Aviva Lev-Ari, PhD, RN 1,977
Pacemakers, Implantable Cardioverter Defibrillators (ICD) and Cardiac Resynchronization Therapy (CRT) – Justin D Pearlman, MD, PhD, FACC and Aviva Lev-Ari, PhD, RN 1,967
Problems of vegetarianism – Sudipta Saha, PhD 1,903
Sexed Semen and Embryo Selection in Human Reproduction and Fertility Treatment – Sudipta Saha, PhD 1,844
DNA Structure and Oligonucleotides – Larry H Bernstein, MD, FCAP 1,796
Targeting the Wnt Pathway [7.11] – Larry H Bernstein, MD, FCAP 1,759
Biosimilars: CMC Issues and Regulatory Requirements – Aviva Lev-Ari, PhD, RN 1,726
Interaction of enzymes and hormones – Sudipta Saha, PhD 1,716
Nitric Oxide and Platelet Aggregation – Dr. Venkat S. Karra, Ph.D. 1,713
CD47: Target Therapy for Cancer – Tilda Barliya, PhD 1,712
Peroxisome proliferator-activated receptor (PPAR-gamma) Receptors Activation: PPARγ transrepression for Angiogenesis in Cardiovascular Disease and PPARγ transactivation for Treatment of Diabetes –

Aviva Lev-Ari, PhD, RN

1,711
Introduction to Tissue Engineering; Nanotechnology applications

Tilda Barliya, PhD

1,666
Non-small Cell Lung Cancer drugs – where does the Future lie? –

Ritu Saxena, PhD

1,658
Nanotechnology: Detecting and Treating metastatic cancer in the lymph node – Tilda Barliya, PhD 1,583
A Primer on DNA and DNA Replication – Larry H. Bernstein, MD, FCAP 1,572
Lipid Metabolism – Larry H. Bernstein, MD, FCAP 1,568
Outcomes in High Cardiovascular Risk Patients: Prasugrel (Effient) vs. Clopidogrel (Plavix); Aliskiren (Tekturna) added to ACE or added to ARB

Aviva Lev-Ari, PhD, RN

1,532
The SCID Pig: How Pigs are becoming a Great Alternate Model for Cancer Research – Stephen J Williams, PhD 1,489
Biosimilars: Intellectual Property Creation and Protection by Pioneer and by Biosimilar Manufacturers – Aviva Lev-Ari, PhD, RN 1,459

Read Full Post »

Older Posts »